Dr. Dekel Taliaz is an experienced business manager and experimental neuroscientist. He is currently the CEO and Co-founder of Taliaz Ltd., a personalized medicine startup that has developed Predictix, a game-changing Artificial Intelligence algorithm to help clinicians find the right treatment for each of their patients sooner. Dr. Taliaz founded the company upon discovering that while there has been tremendous advances in DNA sequencing and computer technologies, the huge value from the ever-growing genetic and clinical information available today was not being leveraged in clinical practice.
Dr. Taliaz holds a PhD in Neuroscience from the Weizmann Institute in Israel and brings vast expertise in manipulating gene expression to determine genetic factors which underlie psychiatric disorders. He is also the Co–founder and Vice President of the Tech division of Israel Brain Technologies, which unites over 30 brain technology companies. He has previously served as a clinical consultant for Brainsway (TASE:BRIN), a leading global neuromodulation company. Dr. Taliaz has also published numerous, highly-cited papers in leading peer-reviewed medical journals and received several honors and awards for his work.